5th Edition of
International Public Health Conference
March 19-21, 2026 | Singapore
Renal Disease
Nephropathy, often known as renal disease or kidney damage, is the medical term for kidney disease. There are several forms of nephritis, an inflammatory kidney disease, depending on where the inflammation is present. Blood tests can be used to identify inflammation. Nephrosis is a kidney condition without inflammation. Nephrotic syndrome and nephritic syndrome are conditions that can result from nephrosis and nephritis, respectively. Kidney disease often results in a partial loss of renal function and can lead to kidney failure, which is the total loss of kidney function. The final stage of kidney disease, kidney failure, can only be treated with dialysis or a kidney transplant. Chronic kidney disease is characterised by persistent, structurally or functionally abnormal kidney conditions that persist for more than three years.
David John Wortley
International Society of Digital Medicine (ISDM), United Kingdom
Bob Esquerre
Esquerre Fitness Group International, United States
Kyrisakos Kouveliotis
Berlin School of Business and Innovation, GermanySubmit your abstract Today
Title : Spillover at the edge: Mapping zoonotic disease risk in the wildland-urban interface
Roman Sharnuud, University of Tennessee, United States
Title : AI for good? Expanding our understanding of opinion leaders in a changing digital landscape
Amelia Burke Garcia, NORC at the University of Chicago, United States
Title : Confidence as care: Empowering under represented voices in public health leadership and community engagement
Sheena Yap Chan, The Tao of Self-Confidence, Canada
Title : Redefining eHealth literacy for the digital age: A scoping review to advance equity, engagement, and behaviour change
Comfort Sanuade, Concordia University, Canada
Title : Innovative approaches in public health leadership: Empowering communities for resilient health systems
Mohammad Kamal Hussain, Umm Al-Qura University, Saudi Arabia
Title : Assessing human exposure to key chemical carcinogens diagnostic approaches and interpretation
Vladan Radosavljevic, Military Medical Academy, Serbia